Drawing for CYROLITE

USPTO serial 79166742

CYROLITE

Reviewed by CopyMark Law Group

Reg. 5047326Status 706Renewal
Filing date
Status date
Registration date
Sep 27, 2016
Examiner
ARANT, LUCY
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Need help with CYROLITE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*

Plus Government fees of $1,700

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Scott D. Woldow

Scott D. Woldow Smith, Gambrell & Russell, LLP1055 THOMAS JEFFERSON ST., N.W., SUITE 4Suite 400Washington, DC 20007

Goods and services

ClassDescriptionStatusFirst use
001Chemicals used in industry; industrial chemicals used in the field of science, [ photography, agriculture, horticulture, and forestry; industrial chemicals, namely, chemical auxiliaries and intermediate products for producing pharmaceutical preparations and cosmetics; ] unprocessed artificial resins; unprocessed plastics; [ unprocessed artificial resins in the form of powders, granulates, solutions, emulsions, dispersions and pastes, namely, for use as auxiliaries for producing pharmaceutical preparations; biodegradable polymers for use in the manufacture of medical devices and pharmaceutical preparations; ] acrylic polymers in the nature of chemical preparations for use in the medical and pharmaceutical industry; polymers for electronic materials, namely, molding and extrusion compounds for electronic and packaging industries; polymers [, biopolymers, polymeric additives and bio polymeric additives ] for use in the manufacture of industrial products, consumer and household products, sealants or packaging; unprocessed thermoplastic compounds, thermoplastic elastomer resins and thermoplastic concentrates for use in manufacturing in a wide variety of industries, namely, polymethyl methacrylates; polymethyl methacrylates for use in industryACTIVE—
005[ Pharmaceutical preparations, namely, Antibacterial pharmaceuticals; Antidiabetic pharmaceuticals; Cardiovascular pharmaceuticals; Dermatological pharmaceuticals; Inhaled pharmaceuticals for the treatment of respiratory diseases and disorders; Injectable pharmaceuticals for the treatment of respiratory diseases and disorders; Ocular pharmaceuticals; Pharmaceutical antidepressants; Pharmaceutical anticoagulants; Pharmaceutical appetite suppressants; Pharmaceuticals for the treatment of infectious diseases; Pharmaceuticals for wounds; Pharmaceutical skin lotions; Anti-infective pharmaceuticals; veterinary preparations, namely, veterinary vaccines; veterinary preparations used in livestock breeding, namely, hormones and amino acids; veterinary preparations, namely, pain relief medication; medical and veterinary preparations and articles, namely, Bandages for dressings, bandages for skin wounds and surgical dressings; Dressings for burns; Dressings for wounds, Dressings for surgery; Self adhesive dressings; adjuvants for medical purposes; drug delivery agents in the form of a coating for tablets that facilitate the delivery of a wide range of pharmaceuticals; dental lacquers; glazes for pharmaceutical veterinary and dietetic preparations, namely, glazes for tablets to facilitate the delivery of pharmaceuticals; chemical preparations for medical, pharmaceutical or veterinary purposes, namely, to facilitate the delivery of pharmaceuticals; cellulose esters for pharmaceutical purposes; diagnostic preparations for medical purposes; medicated chewing gum; gamboge for medical purposes, namely, to facilitate the delivery of pharmaceuticals; chemicopharmaceutical preparations, namely, Medical diagnostic reagents for the analysis of body fluids; surgical implants comprising living tissue; capsules sold empty for pharmaceuticals; sanitary preparations for medical use; dietetic foods and dietetic preparations, namely, pasta, crackers, and sugar adapted for medical or veterinary use; dietary supplements; food for babies; plasters for medical purposes; materials for dressings, namely, gauze and wadding for dressings; material for stopping teeth, dental wax; disinfectants for sanitary purposes; preparations for destroying vermin; fungicides, herbicides ]SECTION 71 - CANCELLED—
010[ Pharmaceutical preparations, namely, Antibacterial pharmaceuticals; Antidiabetic pharmaceuticals; Cardiovascular pharmaceuticals; Dermatological pharmaceuticals; Inhaled pharmaceuticals for the treatment of respiratory diseases and disorders; Injectable pharmaceuticals for the treatment of respiratory diseases and disorders; Ocular pharmaceuticals; Pharmaceutical antidepressants; Pharmaceutical anticoagulants; Pharmaceutical appetite suppressants; Pharmaceuticals for the treatment of infectious diseases; Pharmaceuticals for wounds; Pharmaceutical skin lotions; Anti-infective pharmaceuticals; veterinary preparations, namely, veterinary vaccines; veterinary preparations used in livestock breeding, namely, hormones and amino acids; veterinary preparations, namely, pain relief medication; medical and veterinary preparations and articles, namely, Bandages for dressings, bandages for skin wounds and surgical dressings; Dressings for burns; Dressings for wounds, Dressings for surgery; Self adhesive dressings; adjuvants for medical purposes; drug delivery agents in the form of a coating for tablets that facilitate the delivery of a wide range of pharmaceuticals; dental lacquers; glazes for pharmaceutical veterinary and dietetic preparations, namely, glazes for tablets to facilitate the delivery of pharmaceuticals; chemical preparations for medical, pharmaceutical or veterinary purposes, namely, to facilitate the delivery of pharmaceuticals; cellulose esters for pharmaceutical purposes; diagnostic preparations for medical purposes; medicated chewing gum; gamboge for medical purposes, namely, to facilitate the delivery of pharmaceuticals; chemico-pharmaceutical preparations, namely, Medical diagnostic reagents for the analysis of body fluids; surgical implants comprising living tissue; capsules sold empty for pharmaceuticals; sanitary preparations for medical use; dietetic foods and dietetic preparations, namely, pasta, crackers, and sugar adapted for medical or veterinary use; dietary supplements; food for babies; plasters for medical purposes; materials for dressings, namely, gauze and wadding for dressings; material for stopping teeth, dental wax; disinfectants for sanitary purposes; preparations for destroying vermin; fungicides, herbicides ]SECTION 71 - CANCELLED—
017[ Raw or semi-worked rubber, gutta-percha, raw or semi-worked gum; asbestos, mica; ] unprocessed and semi-processed materials, not adapted for a specific use, namely, Polyester sheets for use in the manufacture of labels; Semi-processed plastic in the form of films, sheets, tubes, bars, or rods; semi-processed plastics; Semi-processed plastics in the nature of filtering materials in the chemical industry; vulcanized mineral fibers, plastics synthetic elastomer resin blended with additives and colorants sold in a pellet form, semi-processed cellulose acetate for use in the chemical field and as packing material; Thermoplastic elastomer resins in pellet form for use in further manufacture; extruded plastic in the form of bars, blocks, pellets, rods, sheets, and tubes for use in manufacturing; synthetic and composite materials, namely, Semi-processed synthetic resins, Synthetic plastic as semi-finished products in form of foils, plates, rods, profiles, hoses, tubes, blocks, and Synthetic rubber; glass fiber impregnated with artificial resins for use in construction and the manufacture of building insulation; plastics in extruded form for use in further manufacturing; semi-processed plastics and artificial semi-processed resins being semi-finished products in the form of plastic laminated sheets and panels for use in manufacturing; plastic composite material in the form of profiles for use in manufacturing; plastic in the form of blocks, rods and tubes for general industrial use; semi-finished products, namely, semi-processed acrylic resins; finished or semi-finished products adapted for a specific use, namely, shock-absorbing padding and insulation material in sheet form for use in further manufacturing *, * [, shock absorbing rubber buffers for industrial machinery, and shock buffers of rubber for industrial machinery; ] finished or semi-finished products adapted for a specific use, namely, packaging materials, namely, Industrial packaging containers of rubber, Low-density polyurethane packaging foam, Plastic sheets for use in the manufacture of displays, signs and packaging and Rubber lids, rubber stopper and rubber caps for industrial packaging containers; finished or semi-finished products, namely, Insulation covers for industrial machinery and rubber sleeves for protecting parts of machinery; joint packing for Flexible pipes, not of metal; non-metal hose fittings; finished or semi-finished products adapted for a specific use, namely, Non-metal sealing rings for use as connection seals; plastic sections for use in the manufacture of spacer frames for use as building materials for heat-insulating applications; [ sealing foils of metal for building insulation and adhesive tape for industrial and commercial use; non-metal weather strips for buildings; partly processed friction materials for clutch facings and brake pads; rubber materials for tire restoration and repair; anti-corrosion tape; foam supports for flower arrangements; ] plastic films for fixing, namely, Semi-finished apertured plastic film for use in medical and hygienic products; [ glass fibers for use in the manufacturing of insulating materials; pavement marking tape; rubber pouches for merchandise packaging; protective rubber articles, namely, Unfitted protective rubber sheets for automobile seats; elastic rubber-like material, namely, elastic rubber-like bands used in the manufacture of clothing; threads of plastic for soldering; ] semi-processed plastic for use as a plug; [ cellulose acetate film used as an industrial or commercial packing material; ] packing materials, namely, film used as an industrial or commercial packing; packing materials, namely, plastic film for industrial or commercial packing use; Packing and insulating material; [ stopping materials, namely, door stops of rubber; ] insulating materials; caulking materials; expansion joint fillers; [ damping materials, namely, Sound dampening blankets; barrier materials, namely, acoustical insulation barrier panels; insulating materials of plastic, namely, Sheets of plastic fabric used as an insulating infiltration barrier in building construction; ] flexible pipes, not of metal [ ; insulating sleeves for flexible power lines; flexible tubes of plastic; non-metal flexible pipes; rings of rubber for use as pipe connection seals; valves of rubber or vulcanized fiber not including machine elements, parts and fittings for all of the aforesaid goods ]ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 22, 2026INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 22, 2026NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Feb 22, 202671AGREGISTERED-SEC.71 ACCEPTED—
Feb 9, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 14, 2025ES71TEAS SECTION 71 RECEIVED—
Sep 27, 2025REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Jan 30, 2025RNWLINTERNATIONAL REGISTRATION RENEWED—
Jan 4, 2025INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Dec 13, 2024ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Dec 5, 2024INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Dec 5, 2024INPCINVALIDATION PROCESSED—
Nov 14, 2024INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Mar 14, 2024NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Mar 13, 202471.PREGISTERED - PARTIAL SEC 71 ACCEPTED—
Oct 13, 2023INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Oct 7, 2023INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Sep 6, 2023EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
May 19, 2023ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Mar 27, 2023PR71POST REGISTRATION ACTION MAILED - SEC.71—
Feb 5, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jul 27, 2022ES71TEAS SECTION 71 RECEIVED—
Jan 16, 2018INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Dec 27, 2017INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Apr 27, 2017LIMELIMITATION FROM THE IB EXAMINED AND ENTERED—
Apr 27, 2017COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Mar 31, 2017LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Mar 24, 2017FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 28, 2016FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 28, 2016FIMPFINAL DISPOSITION PROCESSED—
Dec 27, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 27, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 23, 2016OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jul 12, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 22, 2016OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 22, 2016OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jun 22, 2016NPUBNOTICE OF PUBLICATION—
Jun 6, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 29, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 11, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 11, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 5, 2016ALIEASSIGNED TO LIE—
May 3, 2016ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jan 27, 2016CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 25, 2016CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 7, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 7, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 6, 2016ALIEASSIGNED TO LIE—
Dec 16, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 4, 2015RFNTREFUSAL PROCESSED BY IB—
Jun 17, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 17, 2015RFRRREFUSAL PROCESSED BY MPU—
Jun 17, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 16, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 15, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 13, 2015DOCKASSIGNED TO EXAMINER—
Jun 13, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 11, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance